Bryan M. Reasons

Insider Reports History

Entity
Individual
Location
C/O Impax Laboratories, Inc., 30831 Huntwood Avenue, Hayward, CA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bryan M. Reasons:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Director Common Stock 28.7K $36.2K $1.26 Jun 1, 2024 Direct
Aclaris Therapeutics, Inc. Director Restricted Stock Units 0 $0 $1.26 Jun 1, 2024 Direct
Societal CDMO, Inc. Director Common Stock 0 $0 $1.10 Apr 8, 2024 Direct
Mallinckrodt plc EVP & CFO Restricted Stock Units 20.5K Feb 2, 2024 Direct
Aclaris Therapeutics, Inc. Director Stock Option (Right to Buy) 15.8K Jun 1, 2023 Direct
Mallinckrodt plc EVP & CFO Ordinary Shares 0 $37.50 Nov 14, 2023 Direct
Societal CDMO, Inc. Director Stock Option (Right to Buy) 0 Apr 8, 2024 Direct

Insider Reports Filed by Bryan M. Reasons

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Jun 1, 2024 2 $0 4 Jun 4, 2024 Director
SCTL Societal CDMO, Inc. Apr 8, 2024 4 -$320K 4 Apr 8, 2024 Director
NONE Mallinckrodt plc Feb 2, 2024 1 $0 4 Feb 6, 2024 EVP & CFO
MNKTQ Mallinckrodt plc Nov 14, 2023 1 $0 4 Nov 16, 2023 EVP & CFO
SCTL Societal CDMO, Inc. Aug 28, 2023 1 $25K 4 Aug 28, 2023 Director
MNK Mallinckrodt plc Aug 17, 2023 1 -$11.1K 4 Aug 18, 2023 EVP & CFO
MNK Mallinckrodt plc Jun 30, 2023 1 $0 4 Jul 5, 2023 EVP & CFO
ACRS Aclaris Therapeutics, Inc. Jun 1, 2023 4 $0 4 Jun 5, 2023 Director
SCTL Societal CDMO, Inc. May 17, 2023 2 $0 4 May 19, 2023 Director
MNK Mallinckrodt plc Apr 3, 2023 1 $0 4 Apr 5, 2023 EVP & CFO
MNK Mallinckrodt plc Dec 14, 2022 1 $0 4 Dec 22, 2022 EVP & CFO
MNKPF Mallinckrodt plc Jun 16, 2022 2 $0 4 Jun 21, 2022 EVP & CFO
ACRS Aclaris Therapeutics, Inc. Jun 2, 2022 4 $0 4 Jun 6, 2022 Director
SCTL Societal CDMO, Inc. May 18, 2022 2 $0 4 May 20, 2022 Director
ACRS Aclaris Therapeutics, Inc. Jun 3, 2021 2 $0 4 Jun 4, 2021 Director
SCTL Recro Pharma, Inc. Apr 20, 2021 1 $0 4/A May 17, 2021 Director